Protaryx Medical Receives FDA 510(k) Clearance for Its Breakthrough Transseptal Puncture Device
BALTIMORE — Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the proprietary Transseptal Puncture Device. This milestone represents a significant advancement in the Company’s mission to redefine safe, efficient, […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.